Drug
Zevalin Radioimmunotherapy
Zevalin Radioimmunotherapy: highest development phase Phase 1/2, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zevalin Radioimmunotherapy NCT00048737 | Phase 1/2 | Lymphoma |
Latest
No recent events.
Follow Zevalin Radioimmunotherapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.